CD274 and plasma cell myeloma: Moreover, single blockade of PD-1 or dual blockade using anti-PD-1/PD-L1 antibodies plus lenalidomide blocked the cross-talk between myeloma cells and BMSC, thus inducing an anti-myeloma immune response to inhibit cell growth (291).